Indian Firm Secures USD 4.5 Million for Mega BSF Facility

Elmentoz Research Pvt. Ltd. has raised USD 4.5 million in its first seed funding round to expand insect-based protein production and promote antibiotic-free animal nutrition. The investment, supported by angel investors from India and Norway, will fund the establishment of India’s largest Black Soldier Fly (BSF) protein manufacturing plant.

Starting in January 2026, the facility is expected to process nearly 2,000 metric tons of industrial byproducts each month. Designed to meet global cGMP standards, the plant will incorporate advanced automation to ensure consistent quality and scalability.

Founded in 2022 by Dr. Jayashankar Das and Dr. Padmaja Mohanty, the company operates at the intersection of biotechnology and precision animal nutrition. Its proprietary platform integrates genomics, proteomics, and automated manufacturing to create next-generation functional feed ingredients.

Elmentoz markets its products, including antimicrobial peptide–based premixes, insect-derived proteins, and functional oils. These solutions enhance gut health, improve feed conversion efficiency, and strengthen disease resistance in poultry, aquaculture, and pet food sectors. Importantly, they provide a sustainable alternative to antibiotic growth promoters, addressing rising concerns around antimicrobial resistance.

By converting organic waste into high-quality protein through insect bioconversion, the company reduces land and water usage while lowering carbon emissions. The model also supports India’s efforts to reduce dependence on imported feed additives.

With fresh capital in place, Elmentoz aims to accelerate research, expand manufacturing capacity, and position India as a global hub for sustainable, next-generation feed proteins.